Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Healthcare Industry News Abbott’s Volt PFA system delivers strong 12-month AFib outcomes, heart rhythm society 2025 data reveal Explore how Abbott’s Volt™ PFA System is redefining AFib treatment with groundbreaking 12-month results — see why it’s a game-changer in cardiac care. byPallavi MadhirajuApril 27, 2025